Renal angiomyolipoma: diagnosis and treatment
https://doi.org/10.17650/1726-9776-2006-2-2-14-21
Abstract
Renal angiomyolipoma (RAML) is a most common benign tumor. It consists of fat, vascular, epithelioid cells, and smooth-muscle elements. Two types are described: isolated RAML and RAML associated with tuberous sclerosis. Tuberous sclerosis-associated RAML accounts for 20% of the tumors; these lesions are typically larger than RAMLs; they are often bilateral and multiple and tend to grow. The adequate diagnostic tools for RAML include ultrasonography and computed tomography. Fine-needle biopsy can elucidate the diagnosis of RAML in difficult cases. Most minor lesions are asymptomatic and those smaller than 5 cm need only a regular follow-up without intervention. Nephronsparing surgery is recommended if large RAMLs or symptomatic lesions are present. In these cases, the optimum treatment is partial nephrectomy or selective renal embolization. Angioembolization of RAML is a new technique which obviates surgical disadvantages. Positive immunoreactivity to HMB-45 and α-smooth muscle actin is diagnostic for RAML and distinguishes it from renal cell carcinoma.
About the Authors
V. B. Matveyev
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences
Russian Federation
Russian Federation
K. V. Sorokin
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences
Russian Federation
Russian Federation
References
1. Stone C.H., Lee M.W., Amin M.B. et al. Renal Angiomyolipoma. Further Immunophenotypic Characterization of an Expanding Morphologic Spectrum. Arch Pathol Lab Med 2001; 125: 751–8.
2. Nelson C.P., Sanda M.G. Contemporary diagnosis and management of renal angiomyolipoma. J Urol 2002; 168: 1315–25.
3. De Luca S., Terrone C., Rossetti S. R. Management of renal angiomyolipoma: a report of 53 cases. BJU Int 1999; 83: 215.
4. Dickinson M., Ruckle H., Beaghler M. et al. Renal angiomyolipoma: optimal treatment based on size and symptoms. Clin Nephrol 1998; 49 (5): P.281–6.
5. Crino P.B. and Henske E. P. New developments in the neurobiology of the tuberous sclerosis complex. Neurology 1999; 53: 1384.
6. Gomez M.R. Phenotypes of the tuberous sclerosis complex with a revision of diagnostic criteria. Ann NY Acad Sci 1991;615:1.
7. Lendvay T.S., Marshall F.F. The tuberosis sclerosis and its highly variable manifestations. West J Med 2003; 169: 1635–42.
8. Roach E.S., Gomez M.R., Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol 1998;13:624–8.
9. Stillwell T.J., Gomez M.R. and Kelalis P. P. Renal lesions in tuberous sclerosis. J Urol 1987;138: 477.
10. Jozwiak S., Pedich M., Rajszys P. Incidence of hepatic hamartomas in tuberous sclerosis. Arch Dis Child 1992;67:1363.
11. Tsui W.M.S., Colombari R., Portmann B.C. et al. Hepatic angiomyolipoma: a clinicopathologic study of 30 cases and delineation of unusual morphologic variants. Am J Surg Pathol 1999;23: 34–48.
12. Cook J.A., Oliver K., Mueller R.F. et al. A cross sectional study of renal involvement in tuberous sclerosis. J Med Genet 1996; 33: 480.
13. O’Hagan A. R., Ellsworth R., Secic M. et al. Renal manifestations of tuberous sclerosis complex. Clin Pediatr 1996; 35: 483.
14. Niida Y., Stemmer-Rachamimov A., Logrip M. et al. Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions. Am J Hum Genet 2001; 69: 493–503.
15. Bonetti F., Pea M., Martignoni G. et al. Clear cell (‘sugar’) tumor of the lung is a lesion strictly related to angiomyolipoma: the concept of a family of lesions characterized by the presence of the perivascular epithelioid cells (PEC). Pathology 1994; 26: 230–6.
16. Delgado R., de Leon Bojorge, Aldores-Saavedra J. Atypical angiomyolipoma of the kidney: a distinct morphologyc variant that is easily confused with a varity of malignant neoplasm. Cancer 1998; 83: 1581–92.
17. Fernandez A.M., Minguez R., Serrano P. et al. Rapidly-growing renal angiomyolipoma associated with pregnancy. Actas Urol Esp 1994; 18: 755.
18. Henske E.P., Ao X., Short M.P. et al. Frequent progesterone receptor immunoreactivity in tuberous sclerosis-associated renal angiomyolipomas. Mod Pathol 1998; 11: 665.
19. Mourikis D., Chatziioannou A., Antoniou A. et al. Selective arterial embolization in the management of symptomatic renal angiomyolipomas. Eur J Radiol 1999; 32: 153.
20. Bissler J.J., Kingswood J.C. Renal angiomyolipomata. Kidney Int 2004; 66: 924–34.
21. Maizlin Z.V., Gottlieb P., Corat-Simon Y. et al. Various appearances of multiple angiomyolipomas in the same kidney in a patient without tuberous sclerosis. J Ultrasound Med 2002; 21: 211–3.
22. Jinzaki M., Tanimoto A., Narimatsu Y. et al. Angiomyolipoma: imaging findings in lesions with minimal fat. Radiology 1997; 205: 497–502.
23. Roy C., Tuchmann C., Lindner V. et al. Renal cell carcinoma with a fatty component mimicking angiomyolipoma. Br J Radiol 1998; 71: 977–9.
24. Fröhlich T., Brands A., Thon W.F. et al. Angiomyolipoma of the kidney and lymph nodes. World J Urol 1999; 17(2): 123–5.
25. Paivansalo M., Lahde S., Hyvarinen S. et al. Renal angiomyolipoma. Ultrasonographic, CT, angiographic and histologic correlation. Acta Radiol 1991; 32: 239.
26. Martignoni G., Pea M., Bonetti F. et al. Carcinomalike monotypic epithelioid angiomyolipoma in patients without evidence of tuberous: a clinicopathologic and genetic study. Am J Surg Pathol 1998;22: 663–72.
27. Ciancio S.J., Vira M., Simon M.A. et al. Giant bilateral renal angiomyolipomas associated with tuberous sclerosis. Urology 2001; 57: 554.
28. Hsu T.H., O'Hara J., Mehta A. et al. Nephron-sparing nephrectomy for giant renal angiomyolipoma associated with lymphangioleiomyomatosis. Urology 2002; 59 (1):138.
29. Moorhead J.D., Fritzsche P., Hadley H.L. Management of hemorrhage secondary to renal angiomyolipoma with selective arterial embolization. J Urol 1977; 117: 122.
30. Han Y.M., Kim J.K., Rob S.B. et al. Renal angiomyolipoma: selective arterial embolization–effectiveness and changes in angiomyogenic compnents in long-term followup. Radiology 1997; 204 (1): 65–70.
31. Kessler O.J., Gillon G., Neuman M. et al. Management of renal angiomyolipoma: analysis of 15 cases. Eur Urol 1998; 33: 572.
32. Lee W., Kim T.S., Chung J.W. et al. Renal angiomyolipoma: embolotherapy with a mixture of alcohol and iodized oil. J Vasc Intervent Radiol 1998; 9: 255.
33. Hamlin J.A., Smith D.C., Taylor F.C. et al. Renal angiomyolipoma: Long term follow-up of embolization for acute hemorrhage. Can Assoc Radiol J 1997; 48: 191–8.
Review
For citations:
Matveyev V.B., Sorokin K.V. Renal angiomyolipoma: diagnosis and treatment. Cancer Urology. 2006;2(2):14-21. (In Russ.) https://doi.org/10.17650/1726-9776-2006-2-2-14-21
Views:
367
Email this article 